Unusual structural transition of antimicrobial VP1 peptide

The Phenomenon of Vibrational Circular Dichroism Enhancement: A Systematic Survey of Literature Data

While the intensity of vibrational circular dichroism (VCD) signals is commonly 104-105 times smaller than that of corresponding IR signals, several kinds of systems display enhanced VCD spectra with g-values (VCD/IR intensity ratio) above 10-3 and even reaching 5 × 10-2 in some exceptional cases. These systems include transition metal and lanthanide complexes, protein and peptide fibrils, short oligopeptide gels, crystalline compounds, gels and solution aggregates of organic compounds. We review the literature on VCD enhancement, focusing on collecting and analyzing data on enhanced g-values. Special attention is given to the mechanisms proposed to produce these effects.

Aberrant action of amyloidogenic host defense peptides: a new paradigm to investigate neurodegenerative disorders?

Host defense peptides (HDPs) are components of the innate immune system with activity against a broad range of microbes. In some cases, it appears that this activity is mediated by the ability of these peptides to permeabilize microbial membranes via the formation of amyloid associated structures. Recent evidence suggests that the naturally occurring function of the Aβ40 and Aβ42 peptides, which are causative agents of Alzheimer's disease, may be to serve as amyloidogenic HDPs. Here, it is hypothesized that the neurotoxicity of these peptides is related to aberrant use of their amyloid-mediated antimicrobial mechanisms, which provides the as yet unexplored paradigm of a relationship among HDPs, neurodegenerative disorders, and other conditions that could contribute to their understanding and remediation.

On the selectivity and efficacy of defense peptides with respect to cancer cells

Here, we review potential determinants of the anticancer efficacy of innate immune peptides (ACPs) for cancer cells. These determinants include membrane-based factors, such as receptors, phosphatidylserine, sialic acid residues, and sulfated glycans, and peptide-based factors, such as residue composition, sequence length, net charge, hydrophobic arc size, hydrophobicity, and amphiphilicity. Each of these factors may contribute to the anticancer action of ACPs, but no single factor(s) makes an overriding contribution to their overall selectivity and toxicity. Differences between the anticancer actions of ACPs seem to relate to different levels of interplay between these peptide and membrane-based factors.